Diabetic cardiomyopathy refers to the heart disease that develops as a result of diabetes, characterized by structural and functional abnormalities in the heart muscle. This session will explore the pathophysiology of diabetic cardiomyopathy, including the impact of hyperglycemia, insulin resistance, and inflammation on heart tissue. Key topics will include early diagnosis through biomarkers and imaging techniques, as well as emerging therapies aimed at managing or reversing heart damage in diabetic patients. Additionally, we will discuss the role of lifestyle changes, medications, and novel therapeutic approaches in preventing and treating diabetic cardiomyopathy to improve patient outcomes.